Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

J. F. Gainor, H. Rizvi, E. Jimenez Aguilar, F. Skoulidis, B. Y. Yeap, J. Naidoo, S. Khosrowjerdi, M. Mooradian, C. Lydon, P. Illei, J. Zhang, R. Peterson, B. Ricciuti, M. Nishino, J. A. Roth, J. Grishman, D. Anderson, B. P. Little, B. W. Carter, K. ArbourJ. L. Sauter, M. Mino-Kenudson, J. V. Heymach, S. Digumarthy, A. T. Shaw, M. M. Awad, M. D. Hellmann

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%'. Together they form a unique fingerprint.

Medicine & Life Sciences